Tigecycline-resistant Enterococcus faecalis strain isolated from a German intensive care unit patient | Zendy

Guido Werner | Zendy; Sabine Gfrörer | Zendy; Carola Fleige | Zendy; W. Witte | Zendy; Ingo Klare | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Tigecycline-resistant Enterococcus faecalis strain isolated from a German intensive care unit patient

Author(s) -

Guido Werner,

Sabine Gfrörer,

Carola Fleige,

W. Witte,

Ingo Klare

Publication year - 2008

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkn065

Subject(s) - tigecycline , enterococcus faecalis , microbiology and biotechnology , intensive care unit , enterococcus , medicine , strain (injury) , german , biology , antibiotics , intensive care medicine , staphylococcus aureus , bacteria , geography , genetics , archaeology

Institute for LaboratoryMedicine, Vinzenz von Paul Clinics, MarienhospitalStuttgart, Bo¨heimstr. 37, D-70199 Stuttgart, GermanyKeywords: reserpine, omeprazole, glycylcyclines, tetX*Corresponding author. Tel: þ49-3943-679210; Fax: þ49-3943-679207; E-mail: wernerg@rki.de†Present address. Centre for Diagnostic Medicine, Robert BoschHospital Stuttgart, Auerbachstr. 110, D-70376 Stuttgart,Germany.Sir,Tigecycline is a member of the new group of glycylcyclines anda promising new antibiotic of last resort, active against manybacteria including Enterococcus spp.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research